Ercan, A. Et Al. 2012. Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis. ARTHRITIS RESEARCH & THERAPY , vol.14, no.2 .

Ercan, A., Cui, J., Hazen, M. M., Batliwalla, F., Royle, L., Rudd, P. M., ... Coblyn, J. S.(2012). Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis. ARTHRITIS RESEARCH & THERAPY , vol.14, no.2.

Ercan, ALTAN Et Al. "Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis," ARTHRITIS RESEARCH & THERAPY , vol.14, no.2, 2012

Ercan, ALTAN Et Al. "Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis." ARTHRITIS RESEARCH & THERAPY , vol.14, no.2, 2012

Ercan, A. Et Al. (2012) . "Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis." ARTHRITIS RESEARCH & THERAPY , vol.14, no.2.

@article{article, author={ALTAN ERCAN Et Al. }, title={Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis}, journal={ARTHRITIS RESEARCH & THERAPY}, year=2012}